Wells Fargo Maintains Overweight on Disc Medicine, Raises Price Target to $109

Benzinga · 21h ago
Wells Fargo analyst Derek Archila maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from $91 to $109.